(63 days)
Not Found
No
The 510(k) summary describes a mechanical component (movable gantry base) for a CT system and an interventional angiography system. There is no mention of AI/ML in the intended use, device description, or performance studies. The focus is on mechanical movement and integration with existing systems.
No.
The device is described as an optional movable gantry base unit for use with an Aquilion PRIME system to support longitudinal movement and allow acquisition of images in the z-direction (z-axis), which are descriptive of an imaging device rather than a therapeutic device.
No
The device is an optional accessory for a CT system that supports longitudinal movement and image acquisition. It is a component of an imaging system, not a diagnostic device itself. The diagnostic function is performed by the Aquilion PRIME CT System and INFX-8000C Interventional X-Ray System, not by this specific base unit.
No
The device is described as a "movable gantry base unit" and a "Self-Propelled Scan Base Kit," which are clearly hardware components designed to support and move a CT gantry. The description focuses on mechanical movement and integration with existing hardware systems (CT and interventional x-ray).
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use describes a movable gantry base unit for a CT system to facilitate image acquisition in the z-direction. This is a mechanical component used in imaging, not a device intended for the examination of specimens derived from the human body for the purpose of providing information for the diagnosis, monitoring, or treatment of a disease or condition.
- Device Description: The description reinforces that it's an optional kit attached to a CT gantry to support movement and image acquisition. It replaces a patient couch and works with existing imaging systems (CT and interventional X-ray).
- No mention of biological specimens: There is no mention of analyzing blood, urine, tissue, or any other biological samples.
- Imaging Modality: The input imaging modality is Computed Tomography X-Ray, which is an in-vivo imaging technique, not an in-vitro diagnostic method.
IVD devices are specifically designed to perform tests on samples taken from the body. This device is a component of an imaging system used to visualize the inside of the body directly.
N/A
Intended Use / Indications for Use
Optional movable gantry base unit for use with an Aquilion PRIME system to support longitudinal movement and allow acquisition of images in the z-direction (z-axis).
Note: When installed with the movable gantry base unit, Aquilion PRIME can be used with the INFX-8000C system in the same room.
Product codes (comma separated list FDA assigned to the subject device)
JAK
Device Description
The Infinix 4DCT is composed of the INFX-8000C interventional angiography system and the dynamic volume CT system. Aquilion PRIME. This combination enables patient access and efficient workflow for interventional procedures. CGBA-032A, Aquilion PRIME Self-Propelled Scan Base Kit for IVR-CT is an optional kit intended to be used in conjunction with an Aquilion PRIME / INFX-8000C based IVR-CT system. The subject device is attached to the CT gantry to support longitudinal movement and allow image acquisition in the z-direction (Z-axis), both axial and helical. When this option is selected, the standard CT patient couch is replaced with the patient handling system utilized by the interventional x-ray system, Toshiba INFX-8000C. The intended uses and technological characteristics of the Aquilion PRIME CT System and INFX-8000C Interventional X-Ray System with which this device is used, remain the same.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Computed Tomography x-ray system, Interventional X-Ray System
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
This submission includes summary tables detailing the risk analysis and verification/validation testing conducted through bench testing which demonstrates that the requirements for the modifications made to the system have been met. Evaluation of the modified device included, but was not limited to, confirmation that base movement speed, scanogram and axial/helical scan functions, and interlocks including contact detection, performed according to specifications.
Software Documentation for a Moderate Level of Concern, per the FDA guidance document. "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices Document" issued on May 11, 2005, is also included as part of this submission.
Additionally, testing of the modified system was conducted in accordance with the applicable standards published by the International Electrotechnical Commission (IEC) for Medical Devices and CT Systems.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1750 Computed tomography x-ray system.
(a)
Identification. A computed tomography x-ray system is a diagnostic x-ray system intended to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data from the same axial plane taken at different angles. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized caduceus symbol, which is a staff with two snakes coiled around it, and the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged in a circular pattern around the symbol. The caduceus is rendered in black and white, and the text is in a simple, sans-serif font.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
January 12, 2015
Toshiba Medical Systems Corporation % Mr. Paul Biggins Director, Regulatory Affairs Toshiba America Medical Systems, Inc. 2441 Michelle Drive TUSTIN CA 92780
Re: K143223
Trade/Device Name: CGBA-032A, Aquilion™ PRIME Self-Propelled Scan Base Kit for IVR-CT Regulation Number: 21 CFR 892.1750 Regulation Name: Computed tomography x-ray system Regulatory Class: II Product Code: JAK Dated: November 12, 2014 Received: November 13, 2014
Dear Mr. Biggins:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set
1
forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Robert A Ochs
Robert Ochs, Ph.D. Acting Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
2
510(k) Number (if known)
Device Name
CGBA-032A, Aquilion PRIME Self-Propelled Scan Base Kit for IVR-CT
Indications for Use (Describe)
Optional movable gantry base unit for use with an Aquilion PRIME system to support longitudinal movement and allow acquisition of images in the z-direction (z-axis).
Note: When installed with the movable gantry base unit, Aquilion PRIME can be used with the INFX-8000C system in the same room.
Type of Use (Select one or both, as applicable)
Y Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
PLEASE DO NOT WRITE BELOW THIS LINE – CONTINUE ON A SEPARATE PAGE IF NEEDED.
FOR FDA USE ONLY
Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/0 description: The image shows the logo for Toshiba. The word "TOSHIBA" is written in large, bold, red letters. Below the company name is the slogan "Leading Innovation" in black font, followed by three right-pointing arrows.
TOSHIBA AMERICA MEDICAL SYS
2441 Michelle Drive, Tustin, CA 92780 Phone: (714) 730-5000
510(k) SUMMARY
SUBMITTER'S NAME:
Toshiba America Medical Systems, Inc.
-
- ADDRESS: 2441 Michelle Drive Tustin, CA 92780-2068
-
- ESTABLISHMENT REGISTRATION: 2020563
3. CONTACT PERSON:
Paul Biggins Director, Regulatory Affairs (714) 730-5000
-
- Date Prepared: November 7th, 2014
-
- TRADE NAME(S): CGBA-032A, Aquilion™ PRIME Self-Propelled Scan Base Kit for IVR-CT
6. COMMON NAME: Computed Tomography X-Ray System
-
- DEVICE CLASSIFICATION: Class II 21 CFR 892.1750 - Computed Tomography X-Ray System
-
- PRODUCT CODE / DESCRIPTION: JAK - System, X-Ray, Tomography, Computed
-
- PERFORMANCE STANDARD: This device conforms to applicable Performance Standards for Ionizing Radiation Emitting Products [21 CFR, Subchapter J, Part 1020]
10. PREDICATE DEVICES:
| Product | Marketed by | 510(k) Number | Clearance Date | RTA Acceptance
Date |
|--------------------------------------------------------------|------------------------------------|---------------|-------------------|------------------------|
| Aquilion™ ONE Vision Self-
Propelled Scan Base for IVR CT | Toshiba America
Medical Systems | K134025 | September 5, 2014 | N/A |
| Aquilion™ PRIME | Toshiba America
Medical Systems | K141741 | N/A | July 11, 2014 |
| Infinix™ INFX-8000C | Toshiba America
Medical Systems | K113052 | November 22, 2011 | N/A |
4
11. REASON FOR SUBMISSION:
Modification of a cleared device.
The purpose of this submission is to seek market clearance for CGBA-032A, Aquillion PRIME Self-Propelled Scan Base Kit for IVR-CT. This device is an optional kit intended to be used on an Aquilion PRIME / INFX-8000C based IVR-CT system. It is attached to the CT gantry to support longitudinal movement and allow image acquisition in the zdirection (Z-axis), both axial and helical. When this option is selected, the standard CT patient couch is replaced with the patient handling system utilized by the interventional x-ray system, Toshiba INFX-8000C. The Aquilion PRIME Self-Propelled Scan Base Kit for IVR-CT will be used as part of an Aquilion PRIME / INFX-8000C based IVR-CT system. Please note, the intended uses and technological characteristics of the Aquilion PRIME CT System and the INFX-8000C Interventional X-Ray System remains the same. There have been no modifications made to the imaging chains in these FDA cleared devices and the base system software remains the same. Since both systems will be installed in the same room and to prevent interference during use, system interlocks have been incorporated into the systems.
Please note: The terms "Self-Propelled Scan Base", "Moving Base" and "Movement Base" are used interchangeably throughout this submission. They all refer to the same unit.
12. DEVICE DESCRIPTION:
The Infinix 4DCT is composed of the INFX-8000C interventional angiography system and the dynamic volume CT system. Aquilion PRIME. This combination enables patient access and efficient workflow for interventional procedures. CGBA-032A, Aquilion PRIME Self-Propelled Scan Base Kit for IVR-CT is an optional kit intended to be used in conjunction with an Aquilion PRIME / INFX-8000C based IVR-CT system. The subject device is attached to the CT gantry to support longitudinal movement and allow image acquisition in the z-direction (Z-axis), both axial and helical. When this option is selected, the standard CT patient couch is replaced with the patient handling system utilized by the interventional x-ray system, Toshiba INFX-8000C. The intended uses and technological characteristics of the Aquilion PRIME CT System and INFX-8000C Interventional X-Ray System with which this device is used, remain the same.
13. INDICATIONS FOR USE:
Optional movable gantry base unit for use with an Aquilion PRIME system to support longitudinal movement and allow acquisition of images in the z-direction (Z-axis).
14. SUBSTANTIAL EQUIVALENCE:
This device is substantially equivalent to CGBA-033A, Aquilion ONE Movement Base Kit, which received premarket clearance under K134025, marketed by Toshiba America Medical Systems.
CGBA-032A, Aquilion PRIME Self-Propelled Scan Base Kit for IVR-CT, incorporates modifications to the cleared device in order for the self-propelled scan base unit to be connected to an Aquilion PRIME gantry. This allows the CT system to acquire images in the z-direction (Z-axis) when a fixed catheterization table is used for patient support instead of a dedicated CT patient couch. The indications for use, method of operation
5
including the imaging chain, base software and manufacturing process of the CT and Interventional XR systems remain unchanged from the cleared devices.
A complete comparison table is included in this submission. See below for a brief summary of changes from CGBA-033A, Aquilion ONE Vision Self-Propelled Base Kit:
| Item | CGBA-032A, Aquilion™
PRIME Self-Propelled Scan
Base Kit for IVR-CT | CGBA-033A, Aquilion™
ONE Vision Self-Propelled
Scan Base Kit for IVR-CT | Comments |
|------------------------------------------|--------------------------------------------------------------------------|-------------------------------------------------------------------------------|----------|
| CT System | Aquilion™ PRIME | Aquilion™ ONE Vision | Changed |
| Gantry drive | Movement along rails laid on
the floor | Movement along rails laid on
the floor | Same |
| Cabling | Floor cabling | Roof cabling | Same |
| Couch | Fixed catheterization table
(INFX-8000C System) | Fixed catheterization table
(INFX-8000C System) | Same |
| Scan direction | IN/OUT directions | IN/OUT direction | Same |
| Direction of
Scanogram
acquisition | IN/OUT directions | IN/OUT directions | Same |
The Aquilion PRIME (TSX-303A/A, 303A/B and 303A/F) received RTA Acceptance (K141741) as of July 11th, 2014. The changes made to the predicate device (K141741) include implementation of a new detector and optional software features which have been separately cleared under the 510(k) premarket notification process. CGBA-032A, Aquilion PRIME Self-Propelled Scan Base Kit for IVR-CT, is an optional kit intended to be used on an Aquilion PRIME / INFX-8000C based IVR-CT system.
15. SAFETY:
The device is designed and manufactured under the Quality System Requlations as outlined in 21 CFR § 820 and ISO 13485 Standards. This device is in conformance with the applicable parts of the IEC60601-1, IEC60601-1-1, IEC60601-1-2, IEC60601-1-3, IEC60601-1-4, IEC60601-1-6, IEC60601-1-9, IEC60601-2-28, IEC60601-2-32, IEC60601-2-44. IEC60825-1. IEC62304. IEC62366. IEC 60825. NEMA PS 3.1-3.18. NEMA XR-25 and NEMA XR-26. Additionally, this device complies with all applicable requirements of the radiation safety performance standards, as outlined in 21 CFR §1010 and §1020.
16. NON-CLINICAL TESTS
This submission includes summary tables detailing the risk analysis and verification/validation testing conducted through bench testing which demonstrates that the requirements for the modifications made to the system have been met. Evaluation of the modified device included, but was not limited to, confirmation that base movement speed, scanogram and axial/helical scan functions, and interlocks including contact detection, performed according to specifications.
Software Documentation for a Moderate Level of Concern, per the FDA quidance document. "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices Document" issued on May 11, 2005, is also included as part of this submission.
Additionally, testing of the modified system was conducted in accordance with the
6
applicable standards published by the International Electrotechnical Commission (IEC) for Medical Devices and CT Systems.
17. CONCLUSION
The modifications incorporated into CGBA-032A, Aquilion™ PRIME Self-Propelled Scan Base Kit for IVR-CT, do not change the indications for use or the intended use of the previously cleared devices. Based upon bench testing, successful completion of software validation, and application of risk management and design controls, it is concluded that the subject device is safe and effective for its intended use and is substantially equivalent to the predicate device.